Circ_0004771 Accelerates Cell Carcinogenic Phenotypes via Suppressing miR-1253-Mediated DDAH1 Inhibition in Breast Cancer

References

• Seigel R, Naishadham D, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29. doi:10.3322/caac.2120824399786
   PubMed Web of Science ®Google Scholar
• Anastasiadi Z, Lianos GD, Ignatiadou E, Harissis HV, Mitsis M. Breast cancer in young women: an overview. Updates Surg. 2017;69(3):313–317. doi:10.1007/s13304-017-0424-128260181
   PubMed Web of Science ®Google Scholar
• Goldvaser H, Amir E. Role of bisphosphonates in breast cancer therapy. Curr Treat Options Oncol. 2019;20(4):26. doi:10.1007/s11864-019-0623-830874905
   PubMed Web of Science ®Google Scholar
• Ebbesen KK, Kjems J, Hansen TB. Circular RNAs: identification, biogenesis and function. Biochim Biophys Acta. 2016;1859(1):163–168. doi:10.1016/j.bbagrm.2015.07.00726171810
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148. doi:10.1016/j.canlet.2015.06.00326052092
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691. doi:10.1038/s41576-019-0158-731395983
   PubMed Web of Science ®Google Scholar
• Yu T, Wang Y, Fan Y, et al. CircRNAs in cancer metabolism: a review. J Hematol Oncol. 2019;12(1):90. doi:10.1186/s13045-019-0776-831484561
   PubMed Web of Science ®Google Scholar
• Hua X, Sun Y, Chen J, et al. Circular RNAs in drug resistant tumors. Biomed Pharmacother. 2019;118:109233. doi:10.1016/j.biopha.2019.10923331351436
   PubMed Web of Science ®Google Scholar
• Li Z, Chen Z, Hu G, Jiang Y. Roles of circular RNA in breast cancer: present and future. Am J Transl Res. 2019;11(7):3945–3954.31396311
   PubMed Web of Science ®Google Scholar
• Huang E, Fu J, Yu Q, et al. CircRNA hsa_circ_0004771 promotes esophageal squamous cell cancer progression via miR-339-5p/CDC25A axis. Epigenomics. 2020;12(7):587–603. doi:10.2217/epi-2019-040432050790
   PubMed Web of Science ®Google Scholar
• Xie R, Tang J, Zhu X, Jiang H. Silencing of hsa_circ_0004771 inhibits proliferation and induces apoptosis in breast cancer through activation of miR-653 by targeting ZEB2 signaling pathway. Biosci Rep. 2019;39(5):BSR20181919. doi:10.1042/BSR2018191930979827
   PubMed Web of Science ®Google Scholar
• Leiper J, Nandi M, Torondel B, et al. Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13(2):198–203. doi:10.1038/nm154317273169
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang P, Kwak D, et al. Cardiomyocyte dimethylarginine dimethylaminohydrolase-1 (DDAH1) plays an important role in attenuating ventricular hypertrophy and dysfunction. Basic Res Cardiol. 2017;112(5):55. doi:10.1007/s00395-017-0644-z28819685
   PubMed Web of Science ®Google Scholar
• Jacobi J, Sydow K, von Degenfeld G, et al. Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation. 2005;111(11):1431–1438. doi:10.1161/01.CIR.0000158487.80483.0915781754
   PubMed Web of Science ®Google Scholar
• Yung BC, Li J, Zhang M, et al. Lipid nanoparticles composed of quaternary amine-tertiary amine cationic lipid combination (QTsome) for therapeutic delivery of AntimiR-21 for lung cancer. Mol Pharm. 2016;13(2):653–662. doi:10.1021/acs.molpharmaceut.5b0087826741162
   PubMed Web of Science ®Google Scholar
• Ye J, Xu J, Li Y, et al. DDAH1 mediates gastric cancer cell invasion and metastasis via Wnt/β-catenin signaling pathway. Mol Oncol. 2017;11(9):1208–1224. doi:10.1002/1878-0261.1208928580735
   PubMed Web of Science ®Google Scholar
• Gao F, Du Y, Zhang Y, Ren D, Xu J, Chen D. Circ-EZH2 knockdown reverses DDAH1 and CBX3-mediated cell growth and invasion in glioma through miR-1265 sponge activity. Gene. 2020;726:144196. doi:10.1016/j.gene.2019.14419631669648
   PubMed Web of Science ®Google Scholar
• Reddy KRK, Dasari C, Duscharla D, et al. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA). Angiogenesis. 2018;21(1):79–94. doi:10.1007/s10456-017-9587-029150732
   PubMed Web of Science ®Google Scholar
• Hulin JA, Tommasi S, Elliot D, Hu DG, Lewis BC, Mangoni AA. MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1. Sci Rep. 2017;7(1):13996. doi:10.1038/s41598-017-14454-129070803
   PubMed Web of Science ®Google Scholar
• Hulin JA, Tommasi S, Elliot D, Mangoni AA. Small molecule inhibition of DDAH1 significantly attenuates triple negative breast cancer cell vasculogenic mimicry in vitro. Biomed Pharmacother. 2019;111:602–612. doi:10.1016/j.biopha.2018.12.11730611984
   PubMed Web of Science ®Google Scholar
• John-Aryankalayil M, Palayoor ST, Makinde AY, et al. Fractionated radiation alters oncomir and tumor suppressor miRNAs in human prostate cancer cells. Radiat Res. 2012;178(3):105–117. doi:10.1667/RR2703.122827214
   PubMed Web of Science ®Google Scholar
• Pan B, Qin J, Liu X, et al. Identification of serum exosomal hsa-circ-0004771 as a novel diagnostic biomarker of colorectal cancer. Front Genet. 2019;10:1096. doi:10.3389/fgene.2019.0109631737058
   PubMed Web of Science ®Google Scholar
• Altesha MA, Ni T, Khan A, Liu K, Zheng X. Circular RNA in cardiovascular disease. J Cell Physiol. 2019;234(5):5588–5600. doi:10.1002/jcp.2738430341894
   PubMed Web of Science ®Google Scholar
• Kumar L, Shamsuzzama HR, Baghel T, Nazir A. Circular RNAs: the emerging class of non-coding RNAs and their potential role in human neurodegenerative diseases. Mol Neurobiol. 2017;54(9):7224–7234. doi:10.1007/s12035-016-0213-827796758
   PubMed Web of Science ®Google Scholar
• Kristensen LS, Hansen TB, Venø MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2018;37(5):555–565. doi:10.1038/onc.2017.36128991235
   PubMed Web of Science ®Google Scholar
• Zeng K, He B, Yang BB, et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol Cancer. 2018;17(1):160. doi:10.1186/s12943-018-0914-x30454010
   PubMed Web of Science ®Google Scholar
• Xu JZ, Shao CC, Wang XJ, et al. circTADA2As suppress breast cancer progression and metastasis via targeting miR-203a-3p/SOCS3 axis. Cell Death Dis. 2019;10(3):175. doi:10.1038/s41419-019-1382-y30787278
   PubMed Web of Science ®Google Scholar
• Panda AC. Circular RNAs Act as miRNA sponges. Adv Exp Med Biol. 2018;1087:67–79.30259358
   PubMed Web of Science ®Google Scholar
• Cocucci E, Meldolesi J. Ectosomes and exosomes: shedding the confusion between extracellular vesicles. Trends Cell Biol. 2015;25(6):364–372. doi:10.1016/j.tcb.2015.01.00425683921
   PubMed Web of Science ®Google Scholar
• Valencia K, Luis-Ravelo D, Bovy N, et al. miRNA cargo within exosome-like vesicle transfer influences metastatic bone colonization. Mol Oncol. 2014;8(3):689–703. doi:10.1016/j.molonc.2014.01.01224593875
   PubMed Web of Science ®Google Scholar